+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Phacoemulsification Devices Market 2019-2023 - Product Image

Global Phacoemulsification Devices Market 2019-2023

  • ID: 4721505
  • Report
  • Region: Global
  • 119 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Bausch health
  • Carl Zeiss Meditec
  • Johnson&Johnson
  • NIDEK
  • Novartis
  • PhysIOL
  • MORE
Glaucoma surgery combined with cataract surgery via phacoemulsification to gain traction in the market. Concomitant phacoemulsification and glaucoma surgery are together a viable treatment option for patients with both cataract and glaucoma. The minimally invasive glaucoma procedure combined with phacoemulsification results is faster visual rehabilitation and lowers the chances of intraocular pressure (IOP) spikes. The analysts have predicted that the phacoemulsification devices market will register a CAGR of close to 4% by 2023.

Market Overview

Technological advances in phacoemulsification

Many advances are taking place in cataract surgery. With the improvement in cataract surgeries, the results over the past few years has resulted in a positive impact. The most important change was marked by the introduction of phacoemulsification.

Lack of awareness and shortage of trained surgeons

There is a distinct lack of awareness about the importance of eye care across the globe, especially in emerging economies. Factors such as lack of skilled ophthalmologists and consumer knowledge about eye care limit the patient’s accessibility to eye care in emerging markets.

For the detailed list of factors that will drive and challenge the growth of the phacoemulsification devices market during the 2019-2023, view this report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Novartis and PhysIOL, the competitive environment is quite intense. Factors such as the glaucoma surgery combined with cataract surgery via phacoemulsification and the technological advances in phacoemulsification, will provide considerable growth opportunities to phacoemulsification devices manufactures. Bausch Health, Carl Zeiss Meditec, Johnson & Johnson, NIDEK, Novartis, and PhysIOL are some of the major companies covered in this report.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bausch health
  • Carl Zeiss Meditec
  • Johnson&Johnson
  • NIDEK
  • Novartis
  • PhysIOL
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • Phacoemulsification consumables - Market size and forecast 2018-2023
  • Phacoemulsification systems - Market size and forecast 2018-2023
  • Market opportunity by product
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 09: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
  • Market trends
  • Glaucoma surgery combined with cataract surgery via phacoemulsification
  • Increasing popularity of femtosecond laser as an alternative to phacoemulsification
  • Increasing medical tourism for low-cost cataract surgery
PART 10: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 11: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bausch Health
  • Carl Zeiss Meditec
  • Johnson & Johnson
  • NIDEK
  • Novartis
  • PhysIOL
PART 12: APPENDIX
  • Research methodology
  • List of abbreviations
List of Exhibits
Exhibit 01: Years in consideration
Exhibit 02: Global ophthalmology devices market
Exhibit 03: Segments of global ophthalmology devices market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Product - Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Phacoemulsification consumables - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Phacoemulsification consumables - Year-over-year growth 2019-2023 (%)
Exhibit 22: Phacoemulsification systems - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Phacoemulsification systems - Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2018-2023 (%)
Exhibit 27: Geographic comparison
Exhibit 28: Americas - Market size and forecast 2018-2023 ($ millions)
Exhibit 29: Americas - Year-over-year growth 2019-2023 (%)
Exhibit 30: EMEA - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: EMEA - Year-over-year growth 2019-2023 (%)
Exhibit 32: APAC - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: APAC - Year-over-year growth 2019-2023 (%)
Exhibit 34: Key leading countries
Exhibit 35: Market opportunity
Exhibit 36: Decision framework
Exhibit 37: Cataract surgery procedures performed in hospitals in European countries in 2016 (per 100,000 inhabitants)
Exhibit 38: Impact of drivers and challenges
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: Bausch Health - Vendor overview
Exhibit 45: Bausch Health - Business segments
Exhibit 46: Bausch Health - Organizational developments
Exhibit 47: Bausch Health - Geographic focus
Exhibit 48: Bausch Health - Segment focus
Exhibit 49: Bausch Health - Key offerings
Exhibit 50: Bausch Health - Key customers
Exhibit 51: Carl Zeiss Meditec - Vendor overview
Exhibit 52: Carl Zeiss Meditec - Business segments
Exhibit 53: Carl Zeiss Meditec - Organizational developments
Exhibit 54: Carl Zeiss Meditec - Geographic focus
Exhibit 55: Carl Zeiss Meditec - Segment focus
Exhibit 56: Carl Zeiss Meditec - Key offerings
Exhibit 57: Carl Zeiss Meditec - Key customers
Exhibit 58: Johnson & Johnson - Vendor overview
Exhibit 59: Johnson & Johnson - Business segments
Exhibit 60: Johnson & Johnson - Organizational developments
Exhibit 61: Johnson & Johnson - Geographic focus
Exhibit 62: Johnson & Johnson - Segment focus
Exhibit 63: Johnson & Johnson - Key offerings
Exhibit 64: Johnson & Johnson - Key customers
Exhibit 65: NIDEK - Vendor overview
Exhibit 66: NIDEK - Business segments
Exhibit 67: NIDEK - Geographic focus
Exhibit 68: NIDEK - Segment focus
Exhibit 69: NIDEK - Key offerings
Exhibit 70: NIDEK - Key customers
Exhibit 71: Novartis - Vendor overview
Exhibit 72: Novartis - Business segments
Exhibit 73: Novartis - Organizational developments
Exhibit 74: Novartis - Geographic focus
Exhibit 75: Novartis - Segment focus
Exhibit 76: Novartis - Key offerings
Exhibit 77: Novartis - Key customers
Exhibit 78: PhysIOL - Vendor overview
Exhibit 79: PhysIOL - Product segments
Exhibit 80: PhysIOL - Organizational developments
Exhibit 81: PhysIOL - Key offerings
Exhibit 82: PhysIOL - Key customers
Exhibit 83: Validation techniques employed for market sizing
Exhibit 84: List of abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Bausch health
  • Carl Zeiss Meditec
  • Johnson&Johnson
  • NIDEK
  • Novartis
  • PhysIOL
  • MORE
Global Phacoemulsification Devices Market 2019-2023

The analyst recognizes the following companies as the key players in the global phacoemulsification devices market: Bausch Health, Carl Zeiss Meditec, Johnson & Johnson, NIDEK, Novartis, and PhysIOL.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the glaucoma surgery combined with cataract surgery via phacoemulsification.”

According to the report, one of the major drivers for this market is the technological advances in phacoemulsification.

Further, the report states that one of the major factors hindering the growth of this market is the lack of awareness and shortage of trained surgeons.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Bausch health
  • Carl Zeiss Meditec
  • Johnson&Johnson
  • NIDEK
  • Novartis
  • PhysIOL
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4721505
Adroll
adroll